Tag: Videregen

Impact of Videregen’s technology recognised as it joins UK’s Social Stock Exchange

New source of capital for company as pipeline develops IC3 tenants Videregen Limited, a clinical stage regenerative medicine company developing personalised organ replacements, is pleased to announce that it has become a member of the UK Social Stock Exchange (SSX), a platform which links up businesses and investors focused on impact investing. The SSX provides… Read more »

LSP Tenant Videregen reports patent success in the UK and Australia

LSP Tenant Videregen reports patent success in the UK and Australia ic3 tenant┬áVideregen Limited has recently announced progress with its intellectual property portfolio, having patents granted and accepted in the UK and Australia respectively. Videregen, a clinical stage regenerative medicine company, focuses its attention on the development of personalised organ replacements. Its successful UK patent… Read more »